← Return to Not eligible for Immunotherapy. Now what?

Discussion

Not eligible for Immunotherapy. Now what?

Lung Cancer | Last Active: May 22 5:00pm | Replies (58)

Comment receiving replies
@vic83

Sorry for the confusion. I have not yet been given an immunotherapy drug. My Multifocal lung cancer consists of multiple independent cancers in the lungs, usually slow growing. Maybe some are metastasis, but they are considered primary for now because not possible to know. When one is getting too big or in bad position, they threat it. I have had two VAT surgeries (one nodule each time, both stage 1 cancers) and one round of SBRT (for 2 nodules).
They mentioned immunotherapy at one point but then took it off the table after my episode of radiation-induced pneumonitis. But it may not always be off the table.
With my additional problem of pulmonary fibrosis, my risk is higher for pneumonitis episodes with various cancer treatments. I will start an antifibrotic drug for the pulmonary fibrosis.
While they need to do a lot of research, the interesting question is whether such drugs might help protect me against pneumonitis outbreaks from any cancer treatments I need. From that one could ask if such a drug could also be useful for "pure" cancer patients against pneumonitis.....of course the answer to that question has got to be a long way off

Jump to this post


Replies to "Sorry for the confusion. I have not yet been given an immunotherapy drug. My Multifocal lung..."

Thanks for the clarification. I'm also diagnosed with multifocal LC. For some reason I have multiple nodules in both lungs and we're treating them with SBRT as one becomes more solid. So far I've had four instances since 2018. My radiologist is telling me we can't continue to keep radiating, and my oncologist is not wanting to do any surgery like wedge resections. So we're looking at Keytruda, although there isn't any real data yet on whether or not it's effective for nodules. He's also warned me about the risk of pneumonitis due to all the radiation I've had.